Loading the company…
Loading the company…
Families: Thrombectomy, IVC filters & venous stents.
All companies · Product and company coverage
In the last ten years FDA made 5 decisions for Neuravi (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2021 (2). The latest was on 2025-09-25.
| Family | Decisions on record |
|---|---|
| Thrombectomy, IVC filters & venous stents | 5 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2025-09-25 | 510(k) | K251789 | EMBOTRAP III Revascularization Device |
| 2021-10-13 | 510(k) | K212908 | EmboTrap II Revascularization Device, EMBOTRAP III Revascularization Device |
| 2021-07-30 | 510(k) | K211338 | EMBOTRAP III Revascularization Device |
| 2020-07-14 | 510(k) | K193063 | EMBOTRAP III Revascularization Device |
| 2018-05-09 | 510(k) |
| K173452 |
| EmboTrap ll Revascularization Device |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Neuravi.